ASTH
Astrana Health
$38.03
−$0.03 (−0.08%)Sep 10, 2026
Key metrics
The numbers that frame ASTH today
- Market cap
- $2.12B
- P/E (TTM)
- 52.3
- EV / FCF
- 28.6
- Gross margin
- 10.5%
- EV / Sales
- 0.7
- ROIC
- 12.1%
- Div yield
- 0%
- Debt / equity
- 1.2
- 52wk Low
- $18.08
- 52wk High
- $51.60
Growth
Revenue and earnings trend for ASTH
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ASTH
Is Astrana Health a good buy?
Yes. Astrana Health has strong quality and excellent momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Astrana Health is selling at a low price.
What is the market capitalization of ASTH?
Astrana Health's market capitalization is $2.12B.
What is the P/E ratio for ASTH stock?
Astrana Health's current P/E ratio is 52.3.
What is the 52-week high for ASTH stock?
The 52-week high for Astrana Health is $51.60. The current close of $38.03 is 26.3% below that high.
What is the 52-week low for ASTH stock?
The 52-week low for Astrana Health is $18.08. The current close of $38.03 is 110.3% above that low.
Does ASTH stock pay dividends?
Astrana Health does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ASTH?
Astrana Health's Debt / Equity ratio is 1.18.